M&A Deal Summary |
|
|---|---|
| Date | 2008-06-05 |
| Target | Specialized Health Products Intl |
| Sector | Medical Products |
| Buyer(s) | C. R. Bard |
| Sellers(s) | Galen Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 68M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1907 |
| Sector | Medical Products |
| Employees | 14,900 |
| Revenue | 3.7B USD (2016) |
C. R. Bard, Inc. is a multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology, and surgical specialties. C. R. Bard was formed in 1907 and is based in Murray Hill, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 13 of 23 |
| Sector: Medical Products M&A | 10 of 18 |
| Type: Add-on Acquisition M&A Deals | 13 of 22 |
| State: Utah M&A | 3 of 3 |
| Country: United States M&A | 12 of 22 |
| Year: 2008 M&A | 1 of 2 |
| Size (of disclosed) | 14 of 14 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-03-01 |
Venetec International
San Diego, California, United States Venetec International, a manufacturer of the StatLock Line of Catheter Securement Systems. |
Buy | $166M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-12-07 |
LifeStent
Irvine, California, United States LifeStent provides healthcare services. A product family of Edwards Lifesciences Corporation. |
Buy | $74M |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1990 |
| PE ASSETS | 1.0B USD |
| Size | Large |
| Type | Sector Focused |
Galen Partners is a private equity firm that targets investments in the healthcare industry. Areas within healthcare that Galen will consider include medical devices & technology, specialty pharmaceuticals, and information technology/services. Galen typically invests between $10 and $30 million per transaction in companies with a proprietary product or service that have attained revenues above $10 million. Prospective transactions include growth equity investments, complete buyouts, family business or other recapitalizations, going-private transactions, roll-overs of a portion of existing equity, and management buyouts. Galen Partners was formed in 1990 and is based in Stamford, Connecticut.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 26 |
| Sector: Medical Products M&A | 1 of 6 |
| Type: Add-on Acquisition M&A Deals | 9 of 22 |
| State: Utah M&A | 2 of 2 |
| Country: United States M&A | 10 of 26 |
| Year: 2008 M&A | 2 of 3 |
| Size (of disclosed) | 9 of 11 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-06-04 |
Chamberlin Edmonds & Associates
Atlanta, Georgia, United States Chamberlin Edmonds & Associates is a provider of specialized eligibility determination services to hospitals throughout the U.S. CEA guides uninsured patients through complex application processes to secure government and community reimbursement for uncompensated medical care. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-12-10 |
Dow Pharmaceutical Sciences
Petaluma, California, United States Developer, manufacturer and marketer as well as formulator of topical therapies focused on the dermatology market. |
Sell | $285M |
